UPDATE: Benchmark Company Upgrades LivePerson to Buy, Names $17 PT as Stock is Standing in Front of Several Catalysts

In a report published Monday, Benchmark Company analyst Mark W. Schappel upgraded the rating on

from Hold to Buy, and named a $17.00 price target. In the report, Benchmark Company noted, “We are upgrading LPSN to Buy from Hold and establishing a $17 price target. We think this is an appropriate time to re-engage the story, since we believe several factors needed to move the stock appear to be in place today and we think they're sustainable over the medium-term.” LivePerson closed on Friday at $12.88.